PDL BioPharma Announces 2016 Second Quarter Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
PDL BioPharma (PDLI) Declares $0.05 Quarterly Dividend; 6.1% Yield
May 4, 2016 6:52 PM EDTPDL BioPharma (NASDAQ: PDLI) declared a quarterly dividend of $0.05 per share, or $0.2 annualized.
The dividend will be payable on June 13, 2016, to stockholders of record on June 6, 2016, with an ex-dividend date of June 2, 2016.
The annual yield on the dividend is 6.1... More
PDL BioPharma (PDLI) Tops Q1 EPS by 2c
May 4, 2016 6:51 PM EDTPDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.52, $0.02 better than the analyst estimate of $0.50. Revenue for the quarter came in at $103.4 million versus the consensus estimate of $142.05 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
... More